AstraZeneca files for US FDA approval of HUTCHMED lung cancer drug combination

HUTCHMED (China) HKEX:13 said on Tuesday that Anglo-Swedish drugmaker AstraZeneca LSE:AZN had applied to the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to treat patients with advanced lung cancer.ORPATHYS is being jointly developed by AstraZeneca and HUTCHMED…